ANKTESIS
LIVE

Serial Number

98865900

Owner

ImmunityBio, Inc.

Attorney

Alicia M. Passerin

Filing Date

Nov 21, 2024

Add to watchlist:

No watchlists yet
View on USPTO

ANKTESIS Trademark

Serial Number: 98865900

ANKTESIS is a trademark filed by ImmunityBio, Inc. on November 21, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

ImmunityBio, Inc. (6 trademarks)

3530 John Hopkins Court
San Diego, CA 92121

Entity Type: 03

Trademark Details

Filing Date

November 21, 2024

Registration Date

Not Registered

Published for Opposition

September 2, 2025

Goods & Services

Medical services; medical information; providing a website featuring medical information in the fields of immunotherapy, oncology, cancer, immune-oncology, autoimmune diseases, infectious diseases and human diseases; providing medical information relating to immunotherapy, oncology, cancer, immune-oncology, autoimmune diseases, infectious diseases and human diseases

Biological and pharmaceutical cell preparations for medical use in cell therapy for the treatment and prevention of oncologic diseases and disorders, immune-oncologic diseases and disorders, cancer, non-cancerous neoplasia, immunologic dysfunction, immunologic-related diseases, infections, and infectious diseases

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 8, 2026 EXRA
SOU EXTENSION 1 GRANTED
Apr 7, 2026 EX1G
SOU EXTENSION 1 FILED
Apr 7, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 7, 2026 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 28, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 2, 2025 NPUB
PUBLISHED FOR OPPOSITION
Sep 2, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 27, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 4, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 4, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 4, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 4, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 4, 2025 CNEA
NOTIFICATION OF PRIORITY ACTION E-MAILED
May 15, 2025 GPRN
PRIORITY ACTION E-MAILED
May 15, 2025 GPRA
PRIORITY ACTION WRITTEN
May 15, 2025 CPRA
ASSIGNED TO EXAMINER
May 15, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 26, 2025 NWOS
NEW APPLICATION ENTERED
Nov 21, 2024 NWAP